Literature DB >> 31563981

Cannabis use and psychosis: a review of reviews.

Alkomiet Hasan1, Rupert von Keller2, Chris Maria Friemel2, Wayne Hall3, Miriam Schneider4, Dagmar Koethe5,6, F Markus Leweke5,7, Wolfgang Strube2, Eva Hoch2,8.   

Abstract

We conducted a systematic review of meta-analyses and systematic reviews to evaluate the impact of cannabis use on the onset and course of psychoses. Following a systematic literature search of five data bases (2005-2016) and consecutive structured evaluation, we were able to include 26 systematic reviews and meta-analyses. The methodological quality of the included publications were in the range of high and poor. The scientific literature indicates that psychotic illness arises more frequently in cannabis users compared to non-users, cannabis use is associated with a dose-dependent risk of developing psychotic illness, and cannabis users have an earlier onset of psychotic illness compared to non-users. Cannabis use was also associated with increased relapse rates, more hospitalizations and pronounced positive symptoms in psychotic patients. We make recommendations about the type of research that is required to better characterize the relationship between cannabis use and the development and outcomes of psychosis.

Entities:  

Keywords:  CBD; Cannabinoids; Cannabis; Evidence-based medicine; Psychosis; Schizophrenia; THC

Year:  2019        PMID: 31563981     DOI: 10.1007/s00406-019-01068-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  21 in total

1.  International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey.

Authors:  Shannon Gravely; Pete Driezen; Danielle M Smith; Ron Borland; Eric N Lindblom; David Hammond; Ann McNeill; Andrew Hyland; K Michael Cummings; Gary Chan; Mary E Thompson; Christian Boudreau; Nadia Martin; Janine Ouimet; Ruth Loewen; Anne C K Quah; Maciej L Goniewicz; James F Thrasher; Geoffrey T Fong
Journal:  Int J Drug Policy       Date:  2020-04-16

2.  Effects of cannabidiol in cannabis flower: Implications for harm reduction.

Authors:  Laurel P Gibson; Hollis C Karoly; Jarrod M Ellingson; Jost Klawitter; Cristina Sempio; Julia E Squeri; Angela D Bryan; L Cinnamon Bidwell; Kent E Hutchison
Journal:  Addict Biol       Date:  2021-08-31       Impact factor: 4.093

3.  The state of the evidence on the association between state cannabis laws and opioid-related outcomes: A review.

Authors:  Kayla N Tormohlen; Mark C Bicket; Sarah White; Colleen L Barry; Elizabeth A Stuart; Lainie Rutkow; Emma E McGinty
Journal:  Curr Addict Rep       Date:  2021-09-28

Review 4.  Substance-Use Disorders in Children and Adolescents.

Authors:  Rainer Thomasius; Kerstin Paschke; Nicolas Arnaud
Journal:  Dtsch Arztebl Int       Date:  2022-06-24       Impact factor: 8.251

5.  Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.

Authors:  Itxaso González-Ortega; Enrique Echeburúa; Susana Alberich; Miguel Bernardo; Eduard Vieta; Gonzalo Salazar de Pablo; Ana González-Pinto
Journal:  Int J Environ Res Public Health       Date:  2022-06-15       Impact factor: 4.614

6.  The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review.

Authors:  T Jordan Walter; Nina Pocuca; Jared W Young; Mark A Geyer; Arpi Minassian; William Perry
Journal:  Psychiatry Res       Date:  2020-12-29       Impact factor: 3.222

Review 7.  Clinical management of cannabis withdrawal.

Authors:  Jason P Connor; Daniel Stjepanović; Alan J Budney; Bernard Le Foll; Wayne D Hall
Journal:  Addiction       Date:  2022-01-10       Impact factor: 7.256

8.  Cannabis Use in Inpatients With Schizophrenia Spectrum Disorders at a Community Hospital.

Authors:  Olaniyi Olayinka; Chiedozie Ojimba; Brook Alemu; Olalekan Olaolu; Desta Edomias; Olusegun Popoola; Jisha Kallikkadan; Terence Tumenta; Vijay Gayam; Leon Valbrun; Tolu Olupona; Jason Hershberger
Journal:  J Clin Med Res       Date:  2020-03-30

9.  Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample.

Authors:  Humberto Nicolini; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Jorge Ameth Villatoro Velázquez; Beatriz Camarena; Clara Fleiz Bautista; Marycarmen Bustos-Gamiño; Alejandro Aguilar García; Nuria Lanzagorta; María Elena Medina-Mora
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

Review 10.  [Neurodevelopment and cannabis].

Authors:  M-O Krebs; F Demars; A Frajerman; O Kebir; T Jay
Journal:  Bull Acad Natl Med       Date:  2020-04-17       Impact factor: 0.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.